title: Analysis of DNA methylation in pancreatic cancer: an update.
abstract: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor and the fourth common cause of cancer death in the Western world. The lack of effective therapeutic strategies is due to the late diagnosis of this disease. Methylation markers could improve early detection and help in the surveillance of PDAC after treatment. Analysis of hypermethylation in the tumor tissue might help to identify new therapeutic strategies and aid in the understanding of the pathophysiological changes occurring in pancreatic cancer. There are several methods for the detection of methylated events, but methylation-specific PCR (MSP-PCR) is the method of choice if a small number of genes will be tested in a larger set of patients samples. After isolation of the DNA by standard procedure, the DNA is then modified using sodium bisulfide.
authors.affiliation: Department of Surgery, Medizinische Fakultät Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany, christian.pilarsky@mailbox.tu-dresden.de.
authors.forename: Christian
authors.initials: C
authors.lastname: Pilarsky
authors.forename: Robert
authors.initials: R
authors.lastname: Grützmann
mesh_terms: D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D019175:DNA Methylation; D005557:Formaldehyde; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D016612:Paraffin Embedding; D013447:Sulfites / Q000494:pharmacology; D016707:Tissue Fixation
chemical_list: D013447:Sulfites; D005557:Formaldehyde; D004247:DNA; C042345:hydrogen sulfite